Metcalfe A, Lix L M, Johnson J-A, Currie G, Lyon A W, Bernier F, Tough S C
Department of Obstetrics and Gynaecology, University of Calgary, Calgary, AB, Canada.
Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
BJOG. 2015 Dec;122(13):1748-55. doi: 10.1111/1471-0528.13254. Epub 2015 Jan 5.
An obstetric comorbidity index has been developed recently with superior performance characteristics relative to general comorbidity measures in an obstetric population. This study aimed to externally validate this index and to examine the impact of including hospitalisation/delivery records only when estimating comorbidity prevalence and discriminative performance of the obstetric comorbidity index.
Validation study.
Alberta, Canada.
Pregnant women who delivered a live or stillborn infant in hospital (n = 5995).
Administrative databases were linked to create a population-based cohort. Comorbid conditions were identified from diagnoses for the delivery hospitalisation, all hospitalisations and all healthcare contacts (i.e. hospitalisations, emergency room visits and physician visits) that occurred during pregnancy and 3 months pre-conception. Logistic regression was used to test the discriminative performance of the comorbidity index.
Maternal end-organ damage and extended length of stay for delivery.
Although prevalence estimates for comorbid conditions were consistently lower in delivery records and hospitalisation data than in data for all healthcare contacts, the discriminative performance of the comorbidity index was constant for maternal end-organ damage [all healthcare contacts area under the receiver operating characteristic curve (AUC) = 0.70; hospitalisation data AUC = 0.67; delivery data AUC = 0.65] and extended length of stay for delivery (all healthcare contacts AUC = 0.60; hospitalisation data AUC = 0.58; delivery data AUC = 0.58).
The obstetric comorbidity index shows similar performance characteristics in an external population and is a valid measure of comorbidity in an obstetric population. Furthermore, the discriminative performance of the comorbidity index was similar for comorbidities ascertained at the time of delivery, in hospitalisation data or through all healthcare contacts.
近期已开发出一种产科合并症指数,与产科人群中的一般合并症测量方法相比,具有更优的性能特征。本研究旨在对该指数进行外部验证,并探讨仅纳入住院/分娩记录对估计产科合并症指数的合并症患病率和鉴别性能的影响。
验证性研究。
加拿大艾伯塔省。
在医院分娩活产或死产婴儿的孕妇(n = 5995)。
将行政数据库相链接以创建一个基于人群的队列。从分娩住院、所有住院以及孕期和孕前3个月内发生的所有医疗接触(即住院、急诊就诊和医生就诊)的诊断中识别合并症。采用逻辑回归检验合并症指数的鉴别性能。
孕产妇终末器官损害和分娩住院时间延长。
尽管分娩记录和住院数据中合并症的患病率估计始终低于所有医疗接触数据中的患病率,但合并症指数对孕产妇终末器官损害的鉴别性能保持不变[所有医疗接触的受试者工作特征曲线下面积(AUC)= 0.70;住院数据AUC = 0.67;分娩数据AUC = 0.65],对分娩住院时间延长的鉴别性能也保持不变(所有医疗接触AUC = 0.60;住院数据AUC = 0.58;分娩数据AUC = 0.58)。
产科合并症指数在外部人群中显示出相似的性能特征,是产科人群中合并症的有效测量指标。此外,在分娩时、住院数据中或通过所有医疗接触确定的合并症,合并症指数的鉴别性能相似。